🇺🇸 FDA

Drug profile · INN

flotufolastat f-18 gallium

POSLUMA

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

flotufolastat f-18 gallium (POSLUMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN flotufolastat f-18 gallium
Brand POSLUMA
Route INTRAVENOUS
Formulation SOLUTION

Frequently asked questions

What is flotufolastat f-18 gallium?

flotufolastat f-18 gallium (POSLUMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for flotufolastat f-18 gallium?

POSLUMA is a marketed brand name for flotufolastat f-18 gallium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of flotufolastat f-18 gallium?

flotufolastat f-18 gallium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.